Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason T Henry

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Thrombosis and Thrombolysis|March 31, 2024
Management of DOAC-related bleeding in cancer patients: a single center-case seriesSophia Lee, Jeremy A Ross, Ali Zalpour, et al.
JAMA|April 8, 2010
Sudden death during the triathlonKevin M Harris, Jason T Henry, Eric Rohman, et al.
Circulation. Cardiovascular Quality and Outcomes|March 6, 2014
Satisfaction with emergent transfer for percutaneous coronary interventions on patients with ST-segment-elevation myocardial infarction and their familiesJason T Henry, Ellen Christiansen, Ross F Garberich, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
The impact of regional STEMI systems on protocol use and quality improvement initiatives in community hospitals without cardiac catheterization laboratoriesChauncy B Handran, Miranda Kunz, David M Larson, et al.
American Heart Journal|April 9, 2011
Impact of age on treatment and outcomes in ST-elevation myocardial infarctionMarc C Newell, Jason T Henry, Timothy D Henry, et al.
The Oncologist|June 28, 2025
Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumorsApostolia M Tsimberidou, Farshid Dayyani, David Sommerhalder, et al.
Cancer Research|March 7, 2024
Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-Specific Transcriptome and Molecular SubtypeVahid Bahrambeigi, Jaewon J Lee, Vittorio Branchi, et al.
JCO Precision Oncology|July 12, 2021
Comprehensive Clinical and Molecular Characterization of <i>KRAS</i> <sup>G12C</sup>-Mutant Colorectal CancerJason T Henry, Oluwadara Coker, Saikat Chowdhury, et al.
JACC. Cardiovascular Interventions|May 23, 2020
Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac ArrestMohamed A Omer, Jeffrey M Tyler, Timothy D Henry, et al.
Cancer Discovery|August 8, 2023
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted CancerLars D Engstrom, Ruth Aranda, Laura Waters, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Thrombosis and Thrombolysis|March 31, 2024
Management of DOAC-related bleeding in cancer patients: a single center-case seriesSophia Lee, Jeremy A Ross, Ali Zalpour, et al.
JAMA|April 8, 2010
Sudden death during the triathlonKevin M Harris, Jason T Henry, Eric Rohman, et al.
Circulation. Cardiovascular Quality and Outcomes|March 6, 2014
Satisfaction with emergent transfer for percutaneous coronary interventions on patients with ST-segment-elevation myocardial infarction and their familiesJason T Henry, Ellen Christiansen, Ross F Garberich, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
The impact of regional STEMI systems on protocol use and quality improvement initiatives in community hospitals without cardiac catheterization laboratoriesChauncy B Handran, Miranda Kunz, David M Larson, et al.
American Heart Journal|April 9, 2011
Impact of age on treatment and outcomes in ST-elevation myocardial infarctionMarc C Newell, Jason T Henry, Timothy D Henry, et al.
The Oncologist|June 28, 2025
Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumorsApostolia M Tsimberidou, Farshid Dayyani, David Sommerhalder, et al.
Cancer Research|March 7, 2024
Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-Specific Transcriptome and Molecular SubtypeVahid Bahrambeigi, Jaewon J Lee, Vittorio Branchi, et al.
JCO Precision Oncology|July 12, 2021
Comprehensive Clinical and Molecular Characterization of <i>KRAS</i> <sup>G12C</sup>-Mutant Colorectal CancerJason T Henry, Oluwadara Coker, Saikat Chowdhury, et al.
JACC. Cardiovascular Interventions|May 23, 2020
Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac ArrestMohamed A Omer, Jeffrey M Tyler, Timothy D Henry, et al.
Cancer Discovery|August 8, 2023
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted CancerLars D Engstrom, Ruth Aranda, Laura Waters, et al.
Pageof 1